Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Primary Results of the Multicenter ARISE II Study (Analysis of Revascularization in Ischemic Stroke With EmboTrap).

Zaidat OO, Bozorgchami H, Ribó M, Saver JL, Mattle HP, Chapot R, Narata AP, Francois O, Jadhav AP, Grossberg JA, Riedel CH, Tomasello A, Clark WM, Nordmeyer H, Lin E, Nogueira RG, Yoo AJ, Jovin TG, Siddiqui AH, Bernard T, Claffey M, Andersson T.

Stroke. 2018 May;49(5):1107-1115. doi: 10.1161/STROKEAHA.117.020125. Epub 2018 Apr 11.

PMID:
29643261
2.

The Influence of β-Adrenergic Receptor Kinase-1 on Stroke-induced Immunodeficiency Syndrome.

Ross AM, Lee CS, Lutsep H, Clark WM.

J Cardiovasc Nurs. 2018 Mar 29. doi: 10.1097/JCN.0000000000000481. [Epub ahead of print]

PMID:
29601376
3.

Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.

Hess DC, Wechsler LR, Clark WM, Savitz SI, Ford GA, Chiu D, Yavagal DR, Uchino K, Liebeskind DS, Auchus AP, Sen S, Sila CA, Vest JD, Mays RW.

Lancet Neurol. 2017 May;16(5):360-368. doi: 10.1016/S1474-4422(17)30046-7. Epub 2017 Mar 17.

PMID:
28320635
4.

Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis.

Brott TG, Howard G, Roubin GS, Meschia JF, Mackey A, Brooks W, Moore WS, Hill MD, Mantese VA, Clark WM, Timaran CH, Heck D, Leimgruber PP, Sheffet AJ, Howard VJ, Chaturvedi S, Lal BK, Voeks JH, Hobson RW 2nd; CREST Investigators.

N Engl J Med. 2016 Mar 17;374(11):1021-31. doi: 10.1056/NEJMoa1505215. Epub 2016 Feb 18.

5.

Effects of Acute Stroke Serum on Non-Ischemic Cerebral and Mesenteric Vascular Function.

Canavero I, Sherburne HA, Tremble SM, Clark WM, Cipolla MJ.

Transl Stroke Res. 2016 Apr;7(2):156-65. doi: 10.1007/s12975-016-0449-7. Epub 2016 Jan 26.

6.

Characteristics of participants consenting versus declining follow-up for up to 10 years in a randomized clinical trial.

Sheffet AJ, Voeks JH, Mackey A, Brooks W, Clark WM, Hill MD, Howard VJ, Hughes SE, Tom M, Longbottom ME, Brott TG; CREST Investigators.

Clin Trials. 2015 Dec;12(6):657-63. doi: 10.1177/1740774515590807. Epub 2015 Jun 29.

7.

Association of intraprocedural blood pressure and end tidal carbon dioxide with outcome after acute stroke intervention.

Takahashi CE, Brambrink AM, Aziz MF, Macri E, Raines J, Multani-Kohol A, Hinson HE, Lutsep HL, Clark WM, Fields JD.

Neurocrit Care. 2014 Apr;20(2):202-8. doi: 10.1007/s12028-013-9921-3.

PMID:
24114519
8.

Biodiesel transesterification kinetics monitored by pH measurement.

Clark WM, Medeiros NJ, Boyd DJ, Snell JR.

Bioresour Technol. 2013 May;136:771-4. doi: 10.1016/j.biortech.2013.03.089. Epub 2013 Mar 21.

PMID:
23570721
9.

Dabigatran etexilate: management in acute ischemic stroke.

Javedani PP, Horowitz BZ, Clark WM, Lutsep HL.

Am J Crit Care. 2013 Mar;22(2):169-76. doi: 10.4037/ajcc2013125.

10.

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Martin RH, Foster LD, Tomsick TA; Interventional Management of Stroke (IMS) III Investigators.

N Engl J Med. 2013 Mar 7;368(10):893-903. doi: 10.1056/NEJMoa1214300. Epub 2013 Feb 7. Erratum in: N Engl J Med. 2013 Mar 28;368(13):1265.

11.

Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).

Hill MD, Brooks W, Mackey A, Clark WM, Meschia JF, Morrish WF, Mohr JP, Rhodes JD, Popma JJ, Lal BK, Longbottom ME, Voeks JH, Howard G, Brott TG; CREST Investigators.

Circulation. 2012 Dec 18;126(25):3054-61. doi: 10.1161/CIRCULATIONAHA.112.120030. Epub 2012 Nov 16.

12.

Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.

Hill MD, Martin RH, Mikulis D, Wong JH, Silver FL, Terbrugge KG, Milot G, Clark WM, Macdonald RL, Kelly ME, Boulton M, Fleetwood I, McDougall C, Gunnarsson T, Chow M, Lum C, Dodd R, Poublanc J, Krings T, Demchuk AM, Goyal M, Anderson R, Bishop J, Garman D, Tymianski M; ENACT trial investigators.

Lancet Neurol. 2012 Nov;11(11):942-50. doi: 10.1016/S1474-4422(12)70225-9. Epub 2012 Oct 8.

PMID:
23051991
13.

Effects of known phenoloxidase inhibitors on hemocyanin-derived phenoloxidase from Limulus polyphemus.

Wright J, Clark WM, Cain JA, Patterson A, Coates CJ, Nairn J.

Comp Biochem Physiol B Biochem Mol Biol. 2012 Nov-Dec;163(3-4):303-8. doi: 10.1016/j.cbpb.2012.07.003. Epub 2012 Aug 3.

PMID:
22885403
14.

Stroke: Treatment for acute stroke--the end of the citicoline saga.

Clark WM, Clark TD.

Nat Rev Neurol. 2012 Sep;8(9):484-5. doi: 10.1038/nrneurol.2012.166. Epub 2012 Aug 7. No abstract available.

PMID:
22868867
15.

Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at standard surgical risk: results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).

Vilain KR, Magnuson EA, Li H, Clark WM, Begg RJ, Sam AD 2nd, Sternbergh WC 3rd, Weaver FA, Gray WA, Voeks JH, Brott TG, Cohen DJ; CREST Investigators.

Stroke. 2012 Sep;43(9):2408-16. Epub 2012 Jul 19.

16.

Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion.

Fields JD, Khatri P, Nesbit GM, Liu KC, Barnwell SL, Lutsep HL, Clark WM, Lansberg MG.

J Neurointerv Surg. 2011 Jun;3(2):151-5. doi: 10.1136/jnis.2010.002766. Epub 2010 Dec 8.

17.

Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial).

Cohen DJ, Stolker JM, Wang K, Magnuson EA, Clark WM, Demaerschalk BM, Sam AD Jr, Elmore JR, Weaver FA, Aronow HD, Goldstein LB, Roubin GS, Howard G, Brott TG; CREST Investigators.

J Am Coll Cardiol. 2011 Oct 4;58(15):1557-65. doi: 10.1016/j.jacc.2011.05.054.

18.

Intracranial hemorrhage complicating carotid artery stenting and carotid endarterectomy.

Clark WM, Brott TG.

Stroke. 2011 Oct;42(10):2720-1. doi: 10.1161/STROKEAHA.111.626788. Epub 2011 Aug 11. No abstract available.

19.

Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke.

Switzer JA, Hess DC, Ergul A, Waller JL, Machado LS, Portik-Dobos V, Pettigrew LC, Clark WM, Fagan SC.

Stroke. 2011 Sep;42(9):2633-5. doi: 10.1161/STROKEAHA.111.618215. Epub 2011 Jul 7.

20.

Drug eluting stents for symptomatic intracranial and vertebral artery stenosis.

Fields JD, Petersen BD, Lutsep HL, Nesbit GM, Liu KC, Dogan A, Lee DS, Clark WM, Barnwell SL.

Interv Neuroradiol. 2011 Jun;17(2):241-7. Epub 2011 Jun 20.

21.

Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Soltani A, Clark WM, Hansmann DR.

Transl Stroke Res. 2011 Jun;2(2):159-70. doi: 10.1007/s12975-011-0077-1. Epub 2011 Apr 15.

PMID:
24323621
22.

Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).

Silver FL, Mackey A, Clark WM, Brooks W, Timaran CH, Chiu D, Goldstein LB, Meschia JF, Ferguson RD, Moore WS, Howard G, Brott TG; CREST Investigators.

Stroke. 2011 Mar;42(3):675-80. doi: 10.1161/STROKEAHA.110.610212. Epub 2011 Feb 9.

23.

Carotid stenting vs surgery: parsing the risk of stroke and MI.

Aksoy O, Kapadia SR, Bajzer C, Clark WM, Shishehbor MH.

Cleve Clin J Med. 2010 Dec;77(12):892-902. doi: 10.3949/ccjm.77a.10074. Review.

PMID:
21147943
24.

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

Fagan SC, Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM, Hall CE, Switzer JA, Ergul A, Hess DC.

Stroke. 2010 Oct;41(10):2283-7. doi: 10.1161/STROKEAHA.110.582601. Epub 2010 Aug 12.

25.

Stenting versus endarterectomy for treatment of carotid-artery stenosis.

Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators.

N Engl J Med. 2010 Jul 1;363(1):11-23. doi: 10.1056/NEJMoa0912321. Epub 2010 May 26. Erratum in: N Engl J Med. 2010 Jul 8;363(2):198. N Engl J Med. 2010 Jul 29;363(5):498.

26.

Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®)).

Soltani A, Singhal R, Obtera M, Roy RA, Clark WM, Hansmann DR.

J Thromb Thrombolysis. 2011 Jan;31(1):71-84. doi: 10.1007/s11239-010-0483-3.

27.

Indications and applications of arterial stents for stroke prevention in atherosclerotic intracranial stenosis.

Fields JD, Liu KC, Barnwell SL, Clark WM, Lutsep HL.

Curr Cardiol Rep. 2010 Jan;12(1):20-8. doi: 10.1007/s11886-009-0070-4. Review.

PMID:
20425180
28.

Efficacy of citicoline as an acute stroke treatment.

Clark WM.

Expert Opin Pharmacother. 2009 Apr;10(5):839-46. doi: 10.1517/17460440902835475 .

PMID:
19351232
29.

Keep the three hour TPA window: the lost study of Atlantis.

Clark WM, Madden KP.

J Stroke Cerebrovasc Dis. 2009 Jan;18(1):78-9. doi: 10.1016/j.jstrokecerebrovasdis.2008.11.001. No abstract available. Erratum in: J Stroke Cerebrovasc Dis. 2009 Mar-Apr;18(2):170.

PMID:
19110151
30.

Benign angioedema after thrombolysis for acute stroke.

Papamitsakis NI, Kuyl J, Lutsep HL, Clark WM.

J Stroke Cerebrovasc Dis. 2000 Mar-Apr;9(2):79-81.

PMID:
17895201
31.

Open label tissue plasminogen activator for stroke: the Oregon experience.

Egan R, Lutsep HL, Clark WM, Quinn J, Kearns K, Lockfeld A, Ireland S, Goins S, Buchholz G.

J Stroke Cerebrovasc Dis. 1999 Sep-Oct;8(5):287-90.

PMID:
17895176
32.

The initial acute phase response predicts long-term stroke recovery.

Clark WM, Beamer NB, Wynn M, Coull BM.

J Stroke Cerebrovasc Dis. 1998 Mar-Apr;7(2):128-31.

PMID:
17895069
33.

Adiponectin: spectator or player?

Clark WM.

Stroke. 2005 Sep;36(9):1919-20. No abstract available.

34.

Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra).

McGee HT, Egan RA, Clark WM.

Neurology. 2005 Mar 22;64(6):1095-6. No abstract available.

PMID:
15781843
35.

Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record.

Dalakas MC, Clark WM.

Neurology. 2003 Jun 10;60(11):1736-7. No abstract available.

PMID:
12796522
36.

Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.

Dávalos A, Castillo J, Alvarez-Sabín J, Secades JJ, Mercadal J, López S, Cobo E, Warach S, Sherman D, Clark WM, Lozano R.

Stroke. 2002 Dec;33(12):2850-7.

37.

Intraarterial suction thrombectomy in acute stroke.

Lutsep HL, Clark WM, Nesbit GM, Kuether TA, Barnwell SL.

AJNR Am J Neuroradiol. 2002 May;23(5):783-6.

38.

The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice.

Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel-Poore MP.

Brain Res. 2002 Apr 5;932(1-2):110-9.

PMID:
11911867
39.

Current status of neuroprotective agents in the treatment of acute ischemic stroke.

Lutsep HL, Clark WM.

Curr Neurol Neurosci Rep. 2001 Jan;1(1):13-8. Review.

PMID:
11898495
41.

Potential of anticytokine therapies in central nervous system ischaemia.

Clark WM, Lutsep HL.

Expert Opin Biol Ther. 2001 Mar;1(2):227-37. Review.

PMID:
11727532
42.

A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients.

Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE; Citicoline Stroke Study Group.

Neurology. 2001 Nov 13;57(9):1595-602.

PMID:
11706098
43.

Efficacy of antioxidant therapies in transient focal ischemia in mice.

Clark WM, Rinker LG, Lessov NS, Lowery SL, Cipolla MJ.

Stroke. 2001 Apr;32(4):1000-4.

44.
46.

Association of intracranial stenosis with cortical symptoms or signs.

Lutsep HL, Clark WM.

Neurology. 2000 Sep 12;55(5):716-8.

PMID:
10980744
47.

Lack of interleukin-6 expression is not protective against focal central nervous system ischemia.

Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, Eckenstein F.

Stroke. 2000 Jul;31(7):1715-20.

48.

A highly enantioselective conjugate reduction of 3-arylinden-1-ones using bakers' yeast for the preparation of (S)-3-arylindan-1-ones.

Clark WM, Kassick AJ, Plotkin MA, Eldridge AM, Lantos I.

Org Lett. 1999 Dec 2;1(11):1839-42.

PMID:
10836043
49.
50.

Supplemental Content

Loading ...
Support Center